Search
for

    Research

    5 / 1000+ results

    Community Join

    5 / 440 results

      community PP405: Regrows Hair In 8 Weeks. Is This The Miracle Cure?

       168 upvotes 7 months ago
      PP405 is considered as a potential hair regrowth treatment, but users are skeptical due to past product failures. They compare it to Minoxidil and Finasteride, questioning its effectiveness and the intentions of pharmaceutical companies.

      community Indiamart anyone has used these ones before?

       132 upvotes 1 month ago
      The conversation discusses purchasing hair loss treatments like minoxidil and finasteride from Indiamart, with users advising to stick to reputable Indian pharmaceutical brands. Concerns about product authenticity and safety, especially regarding minoxidil's potential side effects, are also highlighted.

      community Do none pharmaceutical treatments also work?

       5 upvotes 3 months ago
      Topical finasteride and Minoxidil are the most effective treatments for hair loss, with non-pharmaceutical options like PRP, stem cell therapy, and red light caps offering minimal additional benefits. Users suggest sticking to proven treatments unless cost is not a concern.

      community Pelage Pharmaceuticals posted a tweet about PP405.

       41 upvotes 1 month ago
      Pelage Pharmaceuticals' PP405 is discussed with skepticism about its effectiveness in hair regrowth, with some users expressing doubt and others hopeful but cautious. Treatments like finasteride are mentioned as current options, but there's a general sentiment that a cure for hair loss is not imminent.

    Learn

    6 / 801 results

      learn Dexpanthenol

      precursor of vitamin B5 with hair stimulating effects

      learn Osteopontin

      signaling protein that, when suppressed, may grow hair by reducing inflammation and stem cell loss

      learn Saw Palmetto

      a natural and far less effective alternative to Finasteride

      learn KX-826

      • Kintor Pharmaceutical: KX-826, a New Name in Hair Loss Research KX-826 (pyrilutamide) is an experimental topical androgen receptor blocker from Kintor Pharmaceutical. It is not approved as a medicine anywhere; the company reports that its China Phase III trial met its primary endpoint at 24 weeks, but the trial data has been released through corporate announcements rather than peer-reviewed journals and long-term safety is unknown.